Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

Full Year 2024 Results Key Financial Results Revenue: US$7.68b (up 3.8% from ...

Zimmer Biomet Holdings Inc (ZBH) reports robust Q4 performance with nearly 5% constant currency revenue growth and outlines ...

Shares of Zimmer Biomet Holdings Inc. ZBH slipped 5.14% to $102.69 Thursday, on what proved to be an all-around mixed trading ...

The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of ...

Baird lowered the firm’s price target on Zimmer Biomet (ZBH) to $130 from $138 and keeps an Outperform rating on the shares. The firm said ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report) yesterday and set a price ...

CEO Ivan Tornos highlighted that Zimmer Biomet achieved nearly 5% constant currency sales growth in Q4 2024, marking the 12th consecutive quarter of mid-single-digit or better growth. The performance ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...

Inc. reported robust financial results for the fourth quarter of 2024, surpassing analysts' expectations with an earnings per share (EPS) of $2.31, slightly above the forecast of $2.30. The company's ...